Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Oral Language Performance of Deaf and Hard-of-Hearing Students in Mainstream Schools.

Lau THM, Lee KYS, Lam EYC, Lam JHS, Yiu CKM, Tang GWL.

J Deaf Stud Deaf Educ. 2019 Apr 9. pii: enz012. doi: 10.1093/deafed/enz012. [Epub ahead of print]

PMID:
31220286
2.

Pulsus trigeminy and electrolyte derangements: a forgotten primary care presentation.

Wang SSY, Tang GW, Williams G.

J Prim Health Care. 2018 Dec;10(4):348-351. doi: 10.1071/HC18052. No abstract available.

PMID:
31039965
3.

Corrigendum: Acquisition of Classifier Constructions in HKSL by Bimodal Bilingual Deaf Children of Hearing Parents.

Tang GWL, Li J.

Front Psychol. 2018 Sep 19;9:1637. doi: 10.3389/fpsyg.2018.01637. eCollection 2018.

4.

Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses.

Li Q, Deng Q, Chao HP, Liu X, Lu Y, Lin K, Liu B, Tang GW, Zhang D, Tracz A, Jeter C, Rycaj K, Calhoun-Davis T, Huang J, Rubin MA, Beltran H, Shen J, Chatta G, Puzanov I, Mohler JL, Wang J, Zhao R, Kirk J, Chen X, Tang DG.

Nat Commun. 2018 Sep 6;9(1):3600. doi: 10.1038/s41467-018-06067-7.

5.

Acquisition of Classifier Constructions in HKSL by Bimodal Bilingual Deaf Children of Hearing Parents.

Tang GWL, Li J.

Front Psychol. 2018 Jul 23;9:1148. doi: 10.3389/fpsyg.2018.01148. eCollection 2018. Erratum in: Front Psychol. 2018 Sep 19;9:1637.

6.

Clinical efficacy, onset time and safety of bright light therapy in acute bipolar depression as an adjunctive therapy: A randomized controlled trial.

Zhou TH, Dang WM, Ma YT, Hu CQ, Wang N, Zhang GY, Wang G, Shi C, Zhang H, Guo B, Zhou SZ, Feng L, Geng SX, Tong YZ, Tang GW, He ZK, Zhen L, Yu X.

J Affect Disord. 2018 Feb;227:90-96. doi: 10.1016/j.jad.2017.09.038. Epub 2017 Sep 25.

PMID:
29053981
7.

High Resolution Prediction of Calcium-Binding Sites in 3D Protein Structures Using FEATURE.

Zhou W, Tang GW, Altman RB.

J Chem Inf Model. 2015 Aug 24;55(8):1663-72. doi: 10.1021/acs.jcim.5b00367. Epub 2015 Aug 10.

8.

Management of dry eye in UK pharmacies.

Bilkhu PS, Wolffsohn JS, Tang GW, Naroo SA.

Cont Lens Anterior Eye. 2014 Oct;37(5):382-7. doi: 10.1016/j.clae.2014.06.002. Epub 2014 Jul 7.

PMID:
25012919
9.

Knowledge-based fragment binding prediction.

Tang GW, Altman RB.

PLoS Comput Biol. 2014 Apr 24;10(4):e1003589. doi: 10.1371/journal.pcbi.1003589. eCollection 2014 Apr.

10.

High precision prediction of functional sites in protein structures.

Buturovic L, Wong M, Tang GW, Altman RB, Petkovic D.

PLoS One. 2014 Mar 14;9(3):e91240. doi: 10.1371/journal.pone.0091240. eCollection 2014.

11.

A randomized, double-blind, controlled trial of a Chinese herbal formula (Er-Xian decoction) for menopausal symptoms in Hong Kong perimenopausal women.

Zhong LL, Tong Y, Tang GW, Zhang ZJ, Choi WK, Cheng KL, Sze SC, Wai K, Liu Q, Yu BX.

Menopause. 2013 Jul;20(7):767-76. doi: 10.1097/GME.0b013e31827cd3dd.

PMID:
23793167
12.

[Scanning electron microscope observation of plerocercoid from Rana nigromaculata in Guizhou Province].

Xu J, Chen Y, Tang GW, Liu XL.

Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2012 Oct 30;30(5):372-3. Chinese.

PMID:
23484277
13.

Bioinformatics and variability in drug response: a protein structural perspective.

Lahti JL, Tang GW, Capriotti E, Liu T, Altman RB.

J R Soc Interface. 2012 Jul 7;9(72):1409-37. doi: 10.1098/rsif.2011.0843. Epub 2012 May 2. Review.

14.

[Effect of physicochemical factors on infectivity of Spirometra mansoni plerocercoid].

Tang GW, Cheng Y.

Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2011 Oct;29(5):368-71. Chinese.

PMID:
24830200
15.

Comparative modeling: the state of the art and protein drug target structure prediction.

Liu T, Tang GW, Capriotti E.

Comb Chem High Throughput Screen. 2011 Jul;14(6):532-47. Review.

PMID:
21521153
16.

Remote thioredoxin recognition using evolutionary conservation and structural dynamics.

Tang GW, Altman RB.

Structure. 2011 Apr 13;19(4):461-70. doi: 10.1016/j.str.2011.02.007.

17.

[Observation on the ultrastructure of Spirometra mansoni plerocercoid].

Tang GW, Cheng Y, Liu XL, Chang AS.

Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2010 Aug;28(4):312-4. Chinese.

PMID:
21137322
18.

Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccine.

Ault KA, Joura EA, Kjaer SK, Iversen OE, Wheeler CM, Perez G, Brown DR, Koutsky LA, Garland SM, Olsson SE, Tang GW, Ferris DG, Paavonen J, Steben M, Bosch FX, Majewski S, Muñoz N, Sings HL, Harkins K, Rutkowski MA, Haupt RM, Garner EI; FUTURE I and II Study Group.

Int J Cancer. 2011 Mar 15;128(6):1344-53. doi: 10.1002/ijc.25723. Epub 2011 Jan 12.

19.

[Soluble proteins of the plerocercoid of Spirometra mansoni].

Jiang HT, Chen Y, Tang GW, Chen L.

Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2010 Apr;28(2):129-32. Chinese.

PMID:
20666318
20.

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial.

FUTURE I/II Study Group, Dillner J, Kjaer SK, Wheeler CM, Sigurdsson K, Iversen OE, Hernandez-Avila M, Perez G, Brown DR, Koutsky LA, Tay EH, García P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Lehtinen M, Steben M, Bosch FX, Joura EA, Majewski S, Muñoz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan JT, Maansson R, Lu S, Vuocolo S, Hesley TM, Barr E, Haupt R.

BMJ. 2010 Jul 20;341:c3493. doi: 10.1136/bmj.c3493.

21.

Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.

Muñoz N, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, Garcia PJ, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Steben M, Bosch FX, Dillner J, Huh WK, Joura EA, Kurman RJ, Majewski S, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan JT, Lupinacci LC, Giacoletti KE, Sings HL, James MK, Hesley TM, Barr E, Haupt RM.

J Natl Cancer Inst. 2010 Mar 3;102(5):325-39. doi: 10.1093/jnci/djp534. Epub 2010 Feb 5.

PMID:
20139221
22.

Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection.

Olsson SE, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, García P, Ault KA, Garland SM, Leodolter S, Tang GW, Ferris DG, Paavonen J, Lehtinen M, Steben M, Bosch FX, Dillner J, Joura EA, Majewski S, Muñoz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan J, Maansson R, Vuocolo S, Hesley TM, Saah A, Barr E, Haupt RM.

Hum Vaccin. 2009 Oct;5(10):696-704. Epub 2009 Oct 1.

PMID:
19855170
23.

A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions.

Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, García P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Lehtinen M, Steben M, Bosch FX, Dillner J, Joura EA, Majewski S, Muñoz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan J, Maansson R, Lu S, Vuocolo S, Hesley TM, Saah A, Barr E, Haupt RM.

Cancer Prev Res (Phila). 2009 Oct;2(10):868-78. doi: 10.1158/1940-6207.CAPR-09-0031. Epub 2009 Sep 29.

24.

Anxiety and depression in Chinese patients attending an Australian GP clinic.

Tang GW, Dennis S, Comino E, Zwar N.

Aust Fam Physician. 2009 Jul;38(7):552-5.

25.

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years.

Brown DR, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Koutsky LA, Tay EH, Garcia P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Steben M, Bosch FX, Dillner J, Joura EA, Kurman RJ, Majewski S, Muñoz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan J, Lupinacci LC, Giacoletti KE, Sings HL, James M, Hesley TM, Barr E.

J Infect Dis. 2009 Apr 1;199(7):926-35. doi: 10.1086/597307.

PMID:
19236279
26.

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years.

Wheeler CM, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Perez G, Brown DR, Koutsky LA, Tay EH, García P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Steben M, Bosch FX, Dillner J, Joura EA, Kurman RJ, Majewski S, Muñoz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan J, Lupinacci LC, Giacoletti KE, James M, Vuocolo S, Hesley TM, Barr E.

J Infect Dis. 2009 Apr 1;199(7):936-44. doi: 10.1086/597309.

PMID:
19236277
27.

HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine.

Joura EA, Kjaer SK, Wheeler CM, Sigurdsson K, Iversen OE, Hernandez-Avila M, Perez G, Brown DR, Koutsky LA, Tay EH, García P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Lehtinen M, Steben M, Bosch X, Dillner J, Kurman RJ, Majewski S, Muñoz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan J, Lupinacci LC, Giacoletti KE, Lu S, Vuocolo S, Hesley TM, Haupt RM, Barr E.

Vaccine. 2008 Dec 9;26(52):6844-51. doi: 10.1016/j.vaccine.2008.09.073. Epub 2008 Oct 16.

PMID:
18930097
28.

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials.

Joura EA, Leodolter S, Hernandez-Avila M, Wheeler CM, Perez G, Koutsky LA, Garland SM, Harper DM, Tang GW, Ferris DG, Steben M, Jones RW, Bryan J, Taddeo FJ, Bautista OM, Esser MT, Sings HL, Nelson M, Boslego JW, Sattler C, Barr E, Paavonen J.

Lancet. 2007 May 19;369(9574):1693-702.

PMID:
17512854
29.

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.

Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, Tang GW, Ferris DG, Steben M, Bryan J, Taddeo FJ, Railkar R, Esser MT, Sings HL, Nelson M, Boslego J, Sattler C, Barr E, Koutsky LA; Females United to Unilaterally Reduce Endo/Ectocervical Disease (FUTURE) I Investigators.

N Engl J Med. 2007 May 10;356(19):1928-43.

30.

Noninferiority of antibody response to human papillomavirus type 16 in subjects vaccinated with monovalent and quadrivalent L1 virus-like particle vaccines.

Garland SM, Steben M, Hernandez-Avila M, Koutsky LA, Wheeler CM, Perez G, Harper DM, Leodolter S, Tang GW, Ferris DG, Esser MT, Vuocolo SC, Nelson M, Railkar R, Sattler C, Barr E; 012 Study Investigators.

Clin Vaccine Immunol. 2007 Jun;14(6):792-5. Epub 2007 Apr 11.

31.

A pilot study on the effects of a Chinese herbal preparation on menopausal symptoms.

Chan CC, Lau WN, Chiu SP, Chen LC, Choi WK, Tang GW.

Gynecol Endocrinol. 2006 Feb;22(2):70-3.

PMID:
16603430
32.

Bone turnover in young hypoestrogenic women on hormonal therapy.

Chan CC, Tang OS, Lau WN, Tang GW.

Eur J Obstet Gynecol Reprod Biol. 2006 Feb 1;124(2):204-6. Epub 2005 Aug 22.

PMID:
16112793
33.

Use of hormone replacement therapy in the Hong Kong public health sector after the Women's Health Initiative trial.

Leung KY, Ling M, Tang GW.

Maturitas. 2005 Nov-Dec;52(3-4):277-85. Epub 2005 Jun 9.

PMID:
15950409
34.

Continuing professional development--a surrogate for recertification?

Tang GW.

Ann Acad Med Singapore. 2004 Nov;33(6):711-4.

35.

Continuation rate of hormone replacement therapy in Hong Kong public health sector.

Leung KY, Ling M, Tang GW.

Maturitas. 2004 Dec 10;49(4):338-44.

PMID:
15531131
36.

Universal SARS preventive measures in an obstetrics unit: experience of health care staff.

Chan BC, Lee CP, Tang GW.

Am J Infect Control. 2004 Nov;32(7):417-20.

PMID:
15525918
37.

Actinomyces hongkongensis sp. nov. a novel Actinomyces species isolated from a patient with pelvic actinomycosis.

Woo PC, Fung AM, Lau SK, Teng JL, Wong BH, Wong MK, Hon E, Tang GW, Yuen KY.

Syst Appl Microbiol. 2003 Nov;26(4):518-22.

PMID:
14666979
38.

The use of the Minimum Data Set. Home Care in a case management project in Hong Kong.

Leung AC, Liu CP, Tsui LL, Li SY, Tang GW, Yau DC, Chi I, Chow NW.

Care Manag J. 2001 Fall;3(1):8-13.

PMID:
11974577
39.
40.
41.

Psychosocial adjustment in gynecologic cancer survivors: a longitudinal study on risk factors for maladjustment.

Chan YM, Ngan HY, Yip PS, Li BY, Lau OW, Tang GW.

Gynecol Oncol. 2001 Mar;80(3):387-94.

PMID:
11263937
42.

Quantitative ultrasound and symptomatic vertebral fracture risk in Chinese women.

Kung AW, Luk KD, Chu LW, Tang GW.

Osteoporos Int. 1999;10(6):456-61.

PMID:
10663345
43.
44.

Prevention of postoperative nausea and vomiting in gynaecological laparotomies: a comparison of tropisetron and ondansetron.

Tsui SL, Ng KF, Wong LC, Tang GW, Pun TC, Yang JC.

Anaesth Intensive Care. 1999 Oct;27(5):471-6.

45.
46.
47.

The climacteric of Chinese factory workers.

Tang GW.

Maturitas. 1994 Oct;19(3):177-82.

PMID:
7799823
48.

Psychosocial study on Hong Kong Chinese with gynecological cancer.

Ngan HY, Tang GW, Lau OW.

J Psychosom Obstet Gynaecol. 1994 Jun;15(2):111-7.

PMID:
7921006
49.
50.

The value of transabdominal pelvic ultrasonography in monitoring of ovulation induction with gonadotropins.

Chan YF, So WW, Ho PC, Tang GW.

Asia Oceania J Obstet Gynaecol. 1993 Jun;19(2):153-8.

PMID:
8379862

Supplemental Content

Support Center